QID 376382

Date Published: 2022-02-09

QID 376382: Microsoft SQL Server for Linux Containers Elevation of Privilege Vulnerability for February 2022

This vulnerability is not present on servers that are running SQL Server 2019 on Linux bare metal or VMs. This vulnerability is exposed only in SQL Server 2019 Linux container images.

CVE-2022-23276: SQL Server for Linux Containers Elevation of Privilege Vulnerability
SQL Server 2019 GDR, Customers who have deployed SQL Server 2019 Linux container images need to update SQL Server 15.0.2090.38. and Cumulative Update 15 for SQL Server 2019 version 15.0.4198.2.

KB5010657
KB5008996

Affected Software:
SQL Server version from 15.0.2090.0 through 15.0.2090.37.
SQL Server Version from 15.0.4198.0 through 15.0.4198.1

QID Detection Logic(Authenticate):
This QID will check the vulnerable version of SQL Server 2019 GDR on the Linux container.

Successful exploitation allows an attacker to perform escalation of privileges on the vulnerable machine.

CVSS V3 rated as High - 7.8 severity.

CVSS V2 rated as Medium - 4.6 severity.

Solution

Customers are advised to refer to CVE-2022-23276 for more information pertaining to this vulnerability.

Vendor References

CVE-2022-23276 - msrc.microsoft.com/update-guide/vulnerability/CVE-2022-23276

CVEs related to QID 376382

CVE-2022-23276 |

Software Advisories

Advisory ID	Software	Component	Link
KB5010657			support.microsoft.com/en-us/topic/kb5010657-description-of-the-security-update-for-sql-server-2019-gdr-february-8-2022-49c03140-0495-4504-82cd-e920c2ea81bc

By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].